PedAM
Pediatric Disease Annotations & Medicines
| Disease | nephrotic syndrome |
| Phenotype | C0029456|osteoporosis |
| Sentences | 2 |
| PubMedID- 22956461 | Conclusions: our results indicate that csa does not accelerate gc-induced osteoporosis in patients with nephrotic syndrome. |
| PubMedID- 20930431 | Risedronate therapy for the prevention of steroid-induced osteoporosis in patients with minimal-change nephrotic syndrome. |
Page: 1